SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-270798
Filing Date
2023-11-06
Accepted
2023-11-06 06:07:55
Documents
13
Period of Report
2023-11-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d471756d8k.htm   iXBRL 8-K 26460
  Complete submission text file 0001193125-23-270798.txt   187360

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snse-20231106.xsd EX-101.SCH 3872
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20231106_def.xml EX-101.DEF 14097
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20231106_lab.xml EX-101.LAB 23426
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20231106_pre.xml EX-101.PRE 15130
7 EXTRACTED XBRL INSTANCE DOCUMENT d471756d8k_htm.xml XML 5216
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 231378000
SIC: 2834 Pharmaceutical Preparations